当前位置:药药网 / 数据中心 / 儿科标签更改电子表格2021
Lyvispah oral granules
儿科标签批准日期
2021/11/22 0:00:00
特定指示/秒
Spasticity resulting from multiple sclerosis, particularly for the relief of flexor spasms and concomitant pain, clonus, and muscular rigidity in pediatric patients 12 years and older
标签更改摘要
- Approved for the treatment of spasticity resulting from multiple sclerosis in pediatric patients 12 years and older.
- Safety and effectiveness in pediatric patients below the age of 12 years have not been established.
- New dosage form.
- Postmarketing study.